The AD Journey of a Construction Worker: Insights from a 38-Year-Old Caucasian Male

EP: 1.Prevalence and QoL of Hand and Foot AD

EP: 2.Barrier Function and Atopic Dermatitis

EP: 3.Disease Severity's Influence on Atopic Dermatitis Therapeutic Selection

Now Viewing

EP: 4.The AD Journey of a Construction Worker: Insights from a 38-Year-Old Caucasian Male

EP: 5.Empowering Patients: Effective Dermatologic Treatment Selection for Hand and Feet AD

EP: 6.Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms

EP: 7.Practice Pearls for Optimizing the Management of Hand and Foot Atopic Dermatitis

This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on a case study of a 38-year-old Caucasian male construction worker with moderate atopic dermatitis (AD) persisting on his hands and feet.

Despite prior treatments including clobetasol, urea-containing products, ceramide products, and tacrolimus, the patient's symptoms remain uncontrolled, impacting his ability to perform manual labor at work. Dr. Golant emphasizes the challenge of managing hand and foot AD, particularly in patients with moderate disease and significant impact on quality of life.

Early assessment and appropriate use of topical steroids are crucial in AD management, with Dr. Golant cautioning against daily steroid use and emphasizing the importance of understanding patients' treatment regimens to assess disease control accurately.

In cases like the construction worker, exhausted topical options necessitate referral for further evaluation and consideration of alternative topical or systemic therapies. Dr. Golant stresses the importance of tailoring treatment regimens to fit patients' lifestyles and work demands to ensure adherence and efficacy.

The case underscores the complexity of managing hand and foot AD, requiring a personalized approach and shared decision-making between patients and healthcare providers to achieve optimal outcomes. Dr. Golant's insights provide valuable guidance for clinicians in addressing the unique challenges of treating AD in individuals with occupation-related hand and foot involvement.

Video synopsis is AI-generated and reviewed by Dermatology Times® editorial staff.